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ABSTRACT 
Asthma is a chronic disease of bronchi which usually requires continuous medical care. Approaches for drug formulation that easy to 
administer especially for chronic diseases can form valuable therapy. Adhatoda vasica is a plant believed to have several therapeutic effects 
including antiasthmatic properties.It is the leaves,which are of great importance for asthma. Adhatoda vasica nees belonging to family 
Acanthaceae, it is found mainly in India It is also called as vasaka. vasaka herb is used for treating cold cough and asthma. It is a well-known 
ayurvedic medicine for expectorant and helps to ease out the phlegm.Vasaka leaves contain quinazoline alkaloids such as vasicinone, 
vasicine, vasicinol, vasicol granules can be used for the treatment of asthma as they offer advantages such as faster disintegration and 
dissolution as compare to tablet capsules.1 
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1. INTRODUCTION 
Asthma is thought to be caused by a combination 
of genetic and environmental factors. Diagnosis is usually 
based on the pattern of symptoms, response to therapy over 
time, and spirometry. There is no cure for 
asthma. Symptoms can be prevented by avoiding triggers, 
such as allergens and irritants, and by the use of 
inhaled corticosteroids. Asthma attacks all age groups but 
often starts in childhood. Asthma is a chronic disease 
characterized by recurrent attacks of breathlessness and 
wheezing, which vary in severity and frequency from person 
to person.1, 2, 3 
Bronchodilators are recommended for short-term relief of 
symptoms. In those with occasional attacks, no other 
medication is needed. If mild persistent disease is present 
(more than two attacks a week), low-dose inhaled 
corticosteroids or alternatively, a leukotriene antagonist or 
a mast cell stabilizer by mouth is recommended. During an 
asthma attack, the lining of the bronchial tubes swells, 
causing the airways to narrow and reducing flow of air into 
and out of the lungs. 
 
Figure 1: Vasaka leaves 
The medicinal herb expands the airways and provides great 
relief to the bronchitis patients. The active chemical 
constituents present in vasaka leaves are quinazoline, 
vasicinone, vasicine, vasicinol, vasicol, vasicinine, 
adhatodine and 6- hydroxyl vasicine.1 as they offer 
advantages such as faster disintegration and dissolution as 
compared to tablets and capsules, palatable as compared to 
syrups and decoctions, greater acceptability in pediatrics 
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and geriatrics due to lesser risk of choking, time and cost 
required for their manufacture is lesser as compared to 
tablets. 
2. MATERIALS AND METHODS 
2.1 Preparation of Vasaka powder 
Vasaka leaves were collected and authenticated from 
Botanical Survey of India (BSI). Leaves were chopped and 
subjected to grinder and finely powdered and passed 
through sieve no.44. The fine powder is then used for 
preperation of granules by wet granulation method. 
2.2 Selection of excipients 
Starch was chosen as disintegrant, calcium phosphate 
dibasic and talc as bulking agent, magnesium stearate as 
antiadherant, coloring agent to impart colour, PVP-K 30 as a 
binder and methyl and propyl parabens as preservatives. To 
mask the extreme bitter taste of Vasaka, sodium saccharine 
and mannitol was used as sweetener, citric acid as taste 
masker and for flavoring raspberry flavor was used. The 
coloring and flavoring agents used were of food grade 
quality .4,5 
2.3 Preparation of Granules 
Formulation Table 
Granules were prepared by using wet granulation technique. 
Vasaka powder and citric acid were mixed in a mortar to 
which sodium saccharine, mannitol and Raspberry flavor 
were added. This was followed by subsequent addition of 
starch, talc, calcium phosphate dibasic and the parabens. 
Sufficient quantity of distilled water was added to form a 
lumpy mass which was then passed through sieve no. 22 to 
form granules. Granules were dried in the oven. Magnesium 
stearate was added at the end. 6 
 
Table 1: Formulation 
S.N. Ingredients Category F1(mg) F2(mg) F3(mg) F4(mg) 
1 Vasaka Antiasthmatic 125 125 125 125 
2 Starch Disintegrant 150 150 150 150 
3 Magnesium stearate Antiadherant 2.5 2.5 2.5 2.5 
4 Calcium phosphate dibasic Bulking agent 250 250 250 250 
5 Mannnitol Bulking agent 300 300 300 300 
6 Citric acid Taste masker, Sialagogue 110 110 110 110 
7 Methyl paraben Preservative 3 3 3 3 
8 Propyl paraben Preservative 0.5 0.5 0.5 0.5 
9 Raspberry flavor Flavoring agent 0.01 0.01 0.01 0.01 
10 Sodium saccharine Sweetening agent 1.49 1.49 1.49 1.49 
11 Talc Sweetening agent 30 31 35 34 
12 Color Coloring agent 2.5 2.5 2.5 2.5 
13 PVP-K-30 Binder 25 24 20 21 
TOTAL   1000 mg 1000 mg 1000 mg 1000 mg 
 
Table 2: Formulation 
S. N. Ingredients F5(mg) F 6(mg) F 7(mg) F 8(mg) F 9(mg) 
1 Vasaka 125 125 125 125 125 
2 Starch 150 150 150 150 150 
3 Magnesium stearate 2.5 2.5 2.5 2.5 2.5 
4 Calcium phosphate dibasic 250 250 250 250 250 
5 Mannnitol 300 300 300 300 300 
6 
Citric acid 110 110 110 110 110 
7 Methyl paraben 3 3 3 3 3 
8 Propyl paraben 0.5 0.5 0.5 0.5 0.5 
9 Raspberry flavor 0.01 0.01 0.01 0.01 0.01 
10 Sodium saccharine 1.49 1.49 1.49 1.49 1.49 
11 Talc 38 40 36 33 32 
12 Color 2.5 2.5 2.5 2.5 2.5 
13 PVP-K-30 17 15 19 22 23 
TOTAL  1000 mg 1000 mg 1000 mg 1000 mg 1000 mg 
 
2.4 Evaluation of granules 
2.4.1. Angle of Repose 
The angle of repose is the angle formed by the horizontal 
base of the bench surface and the edge of a cone-like pile of 
granules. After the cone from 5 g of sample was built, height 
of the granules forming the cone (h) and the radius (r) of the 
base were measured. The angle of repose (θ) was calculated 
as follows: 
θ = tan-1 (h/r) 
θ =tan-1 (1.2/3.1) 
θ =21.15⁰ 
Results were only considered valid when a symmetrical cone 
of powder was formed. The funnel method was used to 
perform the test 6.(Table 3) 
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Figure 2: Angle of repose Figure 3: Angle of repose (Ө) 
 
2.4.2. Bulk density 
It is the ratio of total mass of powder to the bulk volume of 
powder. 
Db = m / Vo 
Where, m: Mass of the blend=20gm 
Vo: Untapped Volume=45ml 
A graduated glass cylinder was used to perform the test 7. 
(Table 3) 
 
Figure 4: Bulk density 
2.4.3. Tapped Density 
Tapped density is the ratio of mass of powder to the tapped 
volume. Tapped volume is the volume occupied by the same 
mass of the powder after a standard tapping of a measure. 
Dt= m / Vi 
Where, m: Mass of the blend.=20gm 
Vi: Tapped Volume=40ml 
Graduated glass cylinder was used for the test which was 
subjected to 50 tappings and the volume was noted7(Table 
3) 
 
Figure 5: Tapped density 
2.4.4. Loss on drying 
This test was performed by drying a weighed quantity of the 
product in the oven at 105◦C until constant weight was 
obtained.9(Table 3) 
 
Table 3: Results for angle of repose, bulk and tapped density, % LOD. 
Formula Angle of repose Bulk Density Tapped density % of LOD 
F9 21.15◦ 0.444gm/ml 0.5gm/ml 0.12 
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3.1 Drug profile 
Vasaka was chosen as the drug as it is easily available, 
perennial plant and the collection is easier. It also has a well-
established pharmacological profile proving its 
antiasthamatic activity. Vasicine (quinazoline alkaloid) is 
mainly responsible for the bronchodilatory and mucolytic 
effects of the drug. This formulation is mainly intended for 
pediatric and geriatric use hence, the dose of the drug is 
taken to be 125 mg. The dose has been fixed in reference to 
commercially available dosage forms of Vasaka which 
recommends number of tablets or teaspoons of syrup that 
correspond to 125mg of the drug for pediatric use. 
3.2 Excipient profile 
Starch takes up water from the body fluids which cause it to 
swell and thereby leading to disintegration of the granules. 
Calcium phosphate dibasic and mannitol were used as 
bulking agents. Mannitol also aids in faster disintegration 
and acts as a non-calorific sweetening agent. Magnesium 
stearate helps to prevent attrition between the granules and 
formation of fines. Methyl and propyl parabens are nontoxic, 
non-irritating and are used in combination to prevent 
decomposition of the formulation. Citric acid helps to 
stimulate salivary secretions and hence leading to 
disintegration of the granules in the oral cavity, thereby 
obviating the need to consume water along with the 
formulation. Hence, it can be conveniently used by travelling 
patients. Sodium saccharine and the flavoring agent help to 
mask the bitter taste of Vasaka. 
3.3 Angle of repose, bulk and tapped density and % LOD 
. 
The values of angle of repose are below 30◦thereby 
indicating excellent flow properties. Lower values of bulk 
and tapped density indicate higher porosity. % LOD test 
values comply with the official limits and indicate lower 
moisture content in the formulation. 
RESULTS AND DISCUSSION 
Table 4: Results 
S. N. Parameters Observation 
1 Appearance Solid 
2 Colour Brick red 
3 Odour Pleasant 
4 Shape of granules Spherical 
5 Bulk Density 0.444gm/ml 
6 Tapped density 0.5 gm/ml 
7 Hausners ratio 1.13 
8 Carrs compressabililty 
index 
12.1% 
9 Angle of repose 21.15⁰ 
10 %LOD 0.12% 
 
4. CONCLUSION 
Drugs like Vasaka have proven bronchodilatory activity. 
According to Ayurveda, the swarasa or juice of Vasaka leaves 
is administered for respiratory conditions. Many liquid oral 
formulations such as syrups and other formulations such as 
tablets, capsules and lozenges of Vasaka are available in 
market. The solid oral formulations are not readily accepted 
by pediatric and geriatric patients due to the fear of chocking 
whereas the variation in dose and sugar content in liquid 
formulations is of concern. Thus, herbal granules formulated 
from dried aqueous extract of Vasaka have good flow 
properties, greater palatability and disintegrate within 20 
seconds in the oral cavity without the use of water. Hence, it 
can be widely accepted by pediatric and geriatric patients. It 
can also be an ideal choice for travelling patients as it 
obviates the need of water for its administration. As Vasaka 
is a single component in the formulation, the standardization 
is easier. The cost of the formulation is reduced as it is easy 
to manufacture this formulation on a large scale. 
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